Back to Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Investors, LLC
Q3 2026 13F filing
Updated 6 days ago23 disclosed positions worth $1.5B
Portfolio value
$1.5B
Total holdings
23
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KAILERA THERAPEUTICS INC | $257.9M | 22.58M | 17.31% | — |
| 2 | H HEARTFLOW INC | $221.3M | 4.45M | 14.85% | — |
| 3 | A ADARX PHARMACEUTICALS INC | $134.2M | 6.73M | 9.01% | — |
| 4 | A ALKERMES PLC | $127.7M | 3.15M | 8.57% | — |
| 5 | N NEWAMSTERDAM PHARMA COMPANY | $92.6M | 3.81M | 6.21% | — |
| 6 | S SAVARA INC | $90.8M | 17.60M | 6.10% | — |
| 7 | T TARSUS PHARMACEUTICALS INC | $86.2M | 1.10M | 5.78% | — |
| 8 | P PHARVARIS N V | $76.9M | 2.48M | 5.16% | — |
| 9 | S SOLID BIOSCIENCES INC | $70.9M | 9.81M | 4.76% | — |
| 10 | O OLEMA PHARMACEUTICALS INC | $61.2M | 7.09M | 4.11% | — |
| 11 | C HEMAB THERAPEUTICS HOLDINGS INC | $50.9M | 1.65M | 3.42% | — |
| 12 | C CABALETTA BIO INC | $40.7M | 21.21M | 2.73% | — |
| 13 | F FREENOME INC | $37.3M | 2.37M | 2.50% | — |
| 14 | D DYNE THERAPEUTICS INC | $30.6M | 1.90M | 2.05% | — |
| 15 | B C4 THERAPEUTICS INC | $23.9M | 7.17M | 1.60% | — |
| 16 | ? N/A X4 PHARMACEUTICALS INC | $23.1M | 7.97M | 1.55% | — |
| 17 | A ANNEXON INC | $18.8M | 4.44M | 1.26% | — |
| 18 | A ATEA PHARMACEUTICALS INC | $10.8M | 2.08M | 0.73% | — |
| 19 | I DISC MEDICINE INC | $9.2M | 141.2K | 0.62% | — |
| 20 | ? N/A KYVERNA THERAPEUTICS INC | $8.9M | 1.31M | 0.60% | — |
| 21 | R RAPID MICRO BIOSYSTEMS INC | $8.7M | 8.43M | 0.58% | — |
| 22 | ? N/A XILIO THERAPEUTICS INC | $6M | 664.0K | 0.40% | — |
| 23 | N NEWAMSTERDAM PHARMA COMPANY | $1.3M | 100.0K | 0.08% | — |